Pfizer to provide access to low income countries for Covid pill
Darpan News Desk IANS, 16 Nov, 2021 09:08 AM
New Delhi, Nov 16 (IANS) Pfizer Inc and the Medicines Patent Pool (MPP), a United Nations-backed public health organisation working to increase access to life-saving medicines for low- and middle-income countries, on Tuesday announced the signing of a voluntary license agreement for Pfizer's Covid-19 oral antiviral treatment candidate which is administered in combination with low dose ritonavir.
The agreement will enable MPP to facilitate additional production and distribution of the investigational antiviral, pending regulatory authorization or approval, by granting sub-licenses to qualified generic medicine manufacturers, with the goal of facilitating greater access to the global population.
Under the terms of the head license agreement between Pfizer and MPP, qualified generic medicine manufacturers worldwide that are granted sub-licenses will be able to supply PF-07321332 in combination with ritonavir to 95 countries, covering up to approximately 53 per cent of the world's population.
This includes all low-and lower-middle-income countries and some upper-middle-income countries in Sub-Saharan Africa as well as countries that have transitioned from lower-middle to upper-middle-income status in the past five years.
Pfizer will not receive royalties on sales in low-income countries and will further waive royalties on sales in all countries covered by the agreement while Covid-19 remains classified as a Public Health Emergency of International Concern by the World Health Organization.
"Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of Covid-19 infections, decreasing the strain on our healthcare systems and saving lives," said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. "We must work to ensure that all people - regardless of where they live or their circumstances - have access to these breakthroughs, and we are pleased to be able to work with MPP to further our commitment to equity."
"This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low-and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic," said Charles Gore, Executive Director of MPP. "PF-07321332 is to be taken together with ritonavir, an HIV medicine we know well, as we have had a license on it for many years, and we will be working with generic companies to ensure there is enough supply for both Covid-19 and HIV."
The new requirement, which will be phased in over several weeks in August and September, is the most aggressive step the city has taken yet to curb a surge in cases caused by the delta variant.
The findings have the potential to upend past thinking about how the disease is spread. Previously, vaccinated people who got infected were thought to have low levels of virus and to be unlikely to pass it to others. But the new data shows that is not the case with the delta variant.
President Joe Biden is calling on states and local governments to join those that are already handing out dollars for shots. New York, the nation's biggest city, started doling out $100 awards on Friday.
The internal documents also cite studies from Canada, Singapore and Scotland showing that the delta variant may pose a greater risk for hospitalization, intensive care treatment and death than the alpha variant, first detected in the United Kingdom.
The dead included a 82-year-old man in Akseki’s Kepezbeleni neighborhood, where some 80% of the houses were incinerated, the district’s governor, Volkan Hulur, told the the state-run Anadolu Agency.
The four were among those who endured the wrath of the crowd — supporters of Donald Trump aiming to prevent the certification of Joe Biden's election win.
